74 related articles for article (PubMed ID: 9214682)
1. Interaction of oligonucleotide-conjugates with the dipeptide transporter system in Caco-2 cells.
Moore VA; Dunnion DJ; Brown T; Irwin WJ; Akhtar S
Biochem Pharmacol; 1997 May; 53(9):1223-8. PubMed ID: 9214682
[TBL] [Abstract][Full Text] [Related]
2. Suitability of enalapril as a probe of the dipeptide transporter system: in vitro and in vivo studies.
Morrison RA; Chong S; Marino AM; Wasserman MA; Timmins P; Moore VA; Irwin WJ
Pharm Res; 1996 Jul; 13(7):1078-82. PubMed ID: 8842049
[TBL] [Abstract][Full Text] [Related]
3. A rapid screening system to determine drug affinities for the intestinal dipeptide transporter 1: system characterisation.
Moore VA; Irwin WJ; Timmins P; Chong S; Dando SA; Morrison RA
Int J Pharm; 2000 Dec; 210(1-2):15-27. PubMed ID: 11163984
[TBL] [Abstract][Full Text] [Related]
4. Distribution of the dipeptide transporter system along the gastrointestinal tract of rats based on absorption of a stable and specific probe, SQ-29852.
Marino AM; Chong S; Dando SA; Kripalani KJ; Bathala MS; Morrison RA
J Pharm Sci; 1996 Mar; 85(3):282-6. PubMed ID: 8699329
[TBL] [Abstract][Full Text] [Related]
5. A rapid screening system to determine drug affinities for the intestinal dipeptide transporter 2: affinities of ACE inhibitors.
Moore VA; Irwin WJ; Timmins P; Lambert PA; Chong S; Dando SA; Morrison RA
Int J Pharm; 2000 Dec; 210(1-2):29-44. PubMed ID: 11163985
[TBL] [Abstract][Full Text] [Related]
6. Transepithelial transport and stability in blood serum of angiotensin-I-converting enzyme inhibitory dipeptides.
Pentzien AK; Meisel H
Z Naturforsch C J Biosci; 2008; 63(5-6):451-9. PubMed ID: 18669035
[TBL] [Abstract][Full Text] [Related]
7. Modeling of the relationship between dipeptide structure and dipeptide stability, permeability, and ACE inhibitory activity.
Foltz M; van Buren L; Klaffke W; Duchateau GS
J Food Sci; 2009 Sep; 74(7):H243-51. PubMed ID: 19895477
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin-converting enzyme (ACE) inhibitor transport in human intestinal epithelial (Caco-2) cells.
Thwaites DT; Cavet M; Hirst BH; Simmons NL
Br J Pharmacol; 1995 Mar; 114(5):981-6. PubMed ID: 7780654
[TBL] [Abstract][Full Text] [Related]
9. Transport of angiotensin-converting enzyme inhibitors by H+/peptide transporters revisited.
Knütter I; Wollesky C; Kottra G; Hahn MG; Fischer W; Zebisch K; Neubert RH; Daniel H; Brandsch M
J Pharmacol Exp Ther; 2008 Nov; 327(2):432-41. PubMed ID: 18713951
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of intestinal dipeptide transport by the neuropeptide VIP is an anti-absorptive effect via the VPAC1 receptor in a human enterocyte-like cell line (Caco-2).
Anderson CM; Mendoza ME; Kennedy DJ; Raldua D; Thwaites DT
Br J Pharmacol; 2003 Feb; 138(4):564-73. PubMed ID: 12598410
[TBL] [Abstract][Full Text] [Related]
11. Hormonal regulation of dipeptide transporter (PepT1) in Caco-2 cells with normal and anoxia/reoxygenation management.
Sun BW; Zhao XC; Wang GJ; Li N; Li JS
World J Gastroenterol; 2003 Apr; 9(4):808-12. PubMed ID: 12679938
[TBL] [Abstract][Full Text] [Related]
12. Conjugation of dipeptide to fluorescent dyes enhances its affinity for a dipeptide transporter (PEPT1) in human intestinal Caco-2 cells.
Abe H; Satoh M; Miyauchi S; Shuto S; Matsuda A; Kamo N
Bioconjug Chem; 1999; 10(1):24-31. PubMed ID: 9893960
[TBL] [Abstract][Full Text] [Related]
13. Modified (PNA, 2'-O-methyl and phosphoramidate) anti-TAR antisense oligonucleotides as strong and specific inhibitors of in vitro HIV-1 reverse transcription.
Boulmé F; Freund F; Moreau S; Nielsen PE; Gryaznov S; Toulmé JJ; Litvak S
Nucleic Acids Res; 1998 Dec; 26(23):5492-500. PubMed ID: 9826777
[TBL] [Abstract][Full Text] [Related]
14. Activation of the alternative pathway of complement by a phosphorothioate oligonucleotide: potential mechanism of action.
Henry SP; Giclas PC; Leeds J; Pangburn M; Auletta C; Levin AA; Kornbrust DJ
J Pharmacol Exp Ther; 1997 May; 281(2):810-6. PubMed ID: 9152389
[TBL] [Abstract][Full Text] [Related]
15. Uptake of the cephalosporin, cephalexin, by a dipeptide transport carrier in the human intestinal cell line, Caco-2.
Dantzig AH; Bergin L
Biochim Biophys Acta; 1990 Sep; 1027(3):211-7. PubMed ID: 2397233
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, cellular uptake and HIV-1 Tat-dependent trans-activation inhibition activity of oligonucleotide analogues disulphide-conjugated to cell-penetrating peptides.
Turner JJ; Arzumanov AA; Gait MJ
Nucleic Acids Res; 2005; 33(1):27-42. PubMed ID: 15640444
[TBL] [Abstract][Full Text] [Related]
17. Intestinal drug transport via the proton-coupled amino acid transporter PAT1 (SLC36A1) is inhibited by Gly-X(aa) dipeptides.
Frølund S; Langthaler L; Kall MA; Holm R; Nielsen CU
Mol Pharm; 2012 Sep; 9(9):2761-9. PubMed ID: 22853447
[TBL] [Abstract][Full Text] [Related]
18. Substrate specificity of the di/tripeptide transporter in human intestinal epithelia (Caco-2): identification of substrates that undergo H(+)-coupled absorption.
Thwaites DT; Hirst BH; Simmons NL
Br J Pharmacol; 1994 Nov; 113(3):1050-6. PubMed ID: 7858848
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of angiotensin converting enzyme by L-alanyl-4 or 5-substituted-L-prolines and their N alpha-phosphoryl-derivatives.
Alexandrou EN; Liakopoulou-Kyriakides M
Biochem Int; 1990; 21(2):271-8. PubMed ID: 2403366
[TBL] [Abstract][Full Text] [Related]
20. Derivatives of melphalan designed to enhance drug accumulation in cancer cells.
Kupczyk-Subotkowska L; Tamura K; Pal D; Sakaeda T; Siahaan TJ; Stella VJ; Borchardt RT
J Drug Target; 1997; 4(6):359-70. PubMed ID: 9239576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
